Females, n (%) | 209 (62.0) |
Age in years, median (range) | 9.8 (1.9–18.0) |
Disease duration in years, median (range) | 2 (0–7) |
Categories of JIA | |
Oligoarthritis, persistent, n (%) | 155 (46.0) |
Oligoarthritis, extended, n (%) | 9 (2.7) |
Polyarthritis, RF negative, n (%) | 124 (36.8) |
Polyarthritis, RF positive, n (%) | 16 (4.7) |
Enthesitis-related arthritis, n (%) | 12 (3.6) |
Psoriatic arthritis, n (%) | 9 (2.7) |
Undifferentiated arthritis, n (%) | 4 (1.2) |
Physician’s global assessment of disease activity in cm, median (IQR) | 0.0 (0–1.2) |
Parent/patient global assessment of well-being in cm, median (IQR) | 0.5 (0–2.2) |
Number of joints with active arthritis, median (IQR) | 0 (0–1) |
ESR in mm/h, median (IQR) | 5 (2–8) |
JADAS, median (IQR) | 1.7 (0–4.5) |
cJADAS, median (IQR) | 1.6 (0–4.4) |
ESR, erythrocyte sedimentation rate; JADAS, Juvenile Arthritis Disease Activity Score; JIA, juvenile idiopathic arthritis; RF, rheumatoid factor; cJADAS, clinical JADAS.